Biologically active components of Ginkgo biloba given by IV injection for 14 days were associated with improved early cognitive recovery in patients with ischemic stroke.
In studies with an average follow-up of 16 weeks, there was no significant increase in MACE or VTE rates in people with dermatoses treated with JAK-STAT inhibitors.
Patients with stroke have almost double the risk for MI within a year, while those with cervical artery dissection have no increased risk, new data confirmed.
In patients with well-controlled cholesterol after a percutaneous coronary intervention, a higher triglyceride glucose index was tied to higher incidence of adverse clinical outcomes.